An expanded, phenotypically distinct tumor cell subset with low HPV mRNA increases recurrence risk
Human papillomavirus-related (HPV+) cancers harbor a subset of tumor cells expressing certain senescence-related transcripts and reduced levels of HPV mRNAs. We aimed to define this HPV-low population′s biologic traits and clinical significance via integrated analysis of recurrence-prone human HPV+ oropharyngeal cancers (OPCs) and patient-derived xenografts (PDXs) of variable therapy sensitivity. Single-cell mRNA sequencing of PDXs and human tumors detected gene expression profiles in HPV-low cells indicating lack of senescence or terminal differentiation and intact tumorigenic capacity. HPV-low cells in cisplatin-refractory PDXs and particular human OPCs differentially upregulated multiple pathways linked to aggressive tumor biology, including RAS signaling, IL-6 signaling, and EMT. Predicted loss of cell-cell interactions among HPV-low cells reflected reduced epithelial identity, further supporting their more aggressive biology. Accordingly, the size of the pre-treatment HPV-low fraction had strong, independent association with recurrence risk. Genetic subclones within OPCs varied widely in content of HPV-low cells, which were enriched in particular lineages. Our findings uncover novel pro-tumor functions of HPV-low cells and support a central role for them in therapy resistance as well as potential utility as a clinical biomarker. Further elucidating mechanisms of cooperativity and plasticity between HPV-low and high states holds promise to reveal targets in treatment-refractory HPV+ malignancies.
Authors
- Jalal B. Jalaly (ORCID: https://orcid.org/0000-0001-6978-0242)
- Molly R. Patterson (ORCID: https://orcid.org/0000-0001-6246-7181)
- Phyllis A. Gimotty (ORCID: https://orcid.org/0000-0002-3850-9799)
- Noam Auslander (ORCID: https://orcid.org/0000-0002-2037-1517)
- Malay Kumar Sannigrahi (ORCID: https://orcid.org/0000-0002-0377-5771)
- Iain M. Morgan (ORCID: https://orcid.org/0000-0002-4949-3032)
- Ahmed Diab (ORCID: https://orcid.org/0000-0001-6626-7013)
- Lovely Raghav (ORCID: https://orcid.org/0000-0003-2017-5695)
- Devraj Basu (ORCID: https://orcid.org/0000-0003-0896-1490)
- Robert M. Brody (ORCID: https://orcid.org/0000-0001-6639-8830)
- Jean‐Nicolas Gallant (ORCID: https://orcid.org/0000-0003-4696-2013)
- Pavithra Rajagopalan
- Sydney M Schaffer
Institutions
- The Wistar Institute (US)
- Virginia Commonwealth University (US)
- AdventHealth Orlando (US)
- Hospital of the University of Pennsylvania (US)
- Tata Memorial Hospital (IN)
- Advanced Centre for Treatment, Research and Education in Cancer (IN)
- University of Pennsylvania (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.64898/2026.11.10.762907
- Primary Topic
- Head and Neck Cancer Studies
- Type
- preprint